Skip to content
Home

Category: ISSCR

Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway

July 8, 2009 by srrpenna

LA JOLLA, Calif., and BARCELONA, July 8 /PRNewswire/ -- Fate Therapeutics, Inc. announced today the presentation of data from its research on small molecule modulators of the Wnt pathway for osteo-regeneration at the 7th Annual Meeting of the International Society for Stem Cell Research (ISSCR) in Barcelona, Spain. In its findings, the Company demonstrated that selected Wnt activators induce the differentiation of mesenchymal stem cells to mature, bone-forming osteoblasts. The study highlights the potential for using small molecule Wnt activators as osteogenic agents.

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

July 8, 2009 by srrpenna

Findings to be Presented at the International Society of Stem Cell Research (ISSCR) Annual Meeting Demonstrate that Any Stored Blood Sample is a Candidate for iPS Cell Reprogramming

AdaptiveThemes